Bio Path Holdings Stock Market Value
| BPTH Stock | USD 0.06 0.01 14.29% |
| Symbol | Bio |
Bio Path 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Path's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Path.
| 12/06/2025 |
| 01/05/2026 |
If you would invest 0.00 in Bio Path on December 6, 2025 and sell it all today you would earn a total of 0.00 from holding Bio Path Holdings or generate 0.0% return on investment in Bio Path over 30 days. Bio Path is related to or competes with Orgenesis, and Helix BioMedix. Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug developmen... More
Bio Path Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Path's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Path Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 16.6 | |||
| Information Ratio | 0.0433 | |||
| Maximum Drawdown | 55.56 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 16.67 |
Bio Path Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Path's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Path's standard deviation. In reality, there are many statistical measures that can use Bio Path historical prices to predict the future Bio Path's volatility.| Risk Adjusted Performance | 0.0445 | |||
| Jensen Alpha | 0.3445 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0268 | |||
| Treynor Ratio | 0.1795 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Path's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Path Holdings Backtested Returns
Bio Path appears to be out of control, given 3 months investment horizon. Bio Path Holdings secures Sharpe Ratio (or Efficiency) of 0.0236, which signifies that the company had a 0.0236 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Bio Path Holdings, which you can use to evaluate the volatility of the firm. Please makes use of Bio Path's Downside Deviation of 16.6, mean deviation of 5.82, and Risk Adjusted Performance of 0.0445 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bio Path holds a performance score of 1. The firm shows a Beta (market volatility) of 2.79, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bio Path will likely underperform. Please check Bio Path's treynor ratio and the relationship between the semi variance and price action indicator , to make a quick decision on whether Bio Path's price patterns will revert.
Auto-correlation | 0.22 |
Weak predictability
Bio Path Holdings has weak predictability. Overlapping area represents the amount of predictability between Bio Path time series from 6th of December 2025 to 21st of December 2025 and 21st of December 2025 to 5th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Path Holdings price movement. The serial correlation of 0.22 indicates that over 22.0% of current Bio Path price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Bio Path Holdings lagged returns against current returns
Autocorrelation, which is Bio Path otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bio Path's otc stock expected returns. We can calculate the autocorrelation of Bio Path returns to help us make a trade decision. For example, suppose you find that Bio Path has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bio Path regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bio Path otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bio Path otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bio Path otc stock over time.
Current vs Lagged Prices |
| Timeline |
Bio Path Lagged Returns
When evaluating Bio Path's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bio Path otc stock have on its future price. Bio Path autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bio Path autocorrelation shows the relationship between Bio Path otc stock current value and its past values and can show if there is a momentum factor associated with investing in Bio Path Holdings.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Bio OTC Stock
Bio Path financial ratios help investors to determine whether Bio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Path security.